(No ratings)
Dr. Mark D. Fleming, MD, DPhil is a hematopathologist in Boston, MA specializing in hematopathology. He graduated from Harvard Medical School. Dr. Mark D. Fleming, MD, DPhil is affiliated with Dana-Farber Cancer Institute.
Dr. Mark D. Fleming, MD, DPhil graduated from Harvard Medical School. He completed residency at Brigham and Women's Hospital. He is certified by the Board Certification:Hematopathology and has a state license in Massachusetts.
Medical School: Harvard Medical School
Residency: Brigham and Women's Hospital
Board Certification: Board Certification:Hematopathology
Licensed In: Massachusetts
Dr. Mark D. Fleming, MD, DPhil is associated with these hospitals and organizations:
Dr. Mark D. Fleming, MD, DPhil does not have any reviews yet, be the first to leave a review of Dr. Mark D. Fleming, MD, DPhil here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Mark D. Fleming, MD, DPhil. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Millennium Pharmaceuticals, Inc. |
$26,375
$26,375 |
|||
|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated |
$19,500
$19,500 |
|||
| Novartis Pharmaceuticals Corporation |
$3,200
$3,200 |
|||
| Takeda Pharmaceuticals U.S.A., Inc. |
$1,500
$1,500 |
|||
| Luitpold Pharmaceuticals Inc |
$700
$700 |
|||
| Other |
$837
CEREC $448 |
Irrisept $163 |
ENTRE $153 |
ALPROLIX $73 |
| Consulting Fee | $51,275 |
|---|---|
| Food and Beverage | $837 |
Dr. Mark D. Fleming, MD, DPhil has received 3 research payments totaling $204,700.
Dr. Mark Fleming is a specialist in hematopathology. Clinical interests for Dr. Fleming include myelodysplastic syndromes (MDS), genetic disorders, and thalassemia. He attended medical school at Harvard Medical School. He trained at Brigham and Women's Hospital for his residency. He is professionally affiliated with Boston Children's Hospital and Dana-Farber Cancer Institute.